Sepsis & infection

Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial

Crit CarePublished Post-hoc analysis of the VICTAS trial

Authors' conclusion

Serum concentration of Angiotensinogen was more strongly associated with 30-day mortality than either the serum concentrations of renin or lactate in sepsis patients.

Study context

Population
Sepsis patients in the VICTAS cohort
Comparison
Serum angiotensinogen vs lactate and renin for association with mortality
Primary endpoint
30-day mortality (ROC and Kaplan-Meier curve analyses)
Follow-up
30-day

Primary result

As reported in the abstract

30-day mortality
  • Serum angiotensinogen more strongly associated with 30-day mortality than serum renin or lactate

Original publication

Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial. Crit Care. Published 14 October 2024. doi:10.1186/s13054-024-05120-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.